Primary Record
sulfatide
- In stock
- 949 g
- Purity
- 98.4 %
- CAS
- 151122-71-3
Compound Identifiers & Properties
- CAS
- 151122-71-3
- PubChem CID
- 6451121
- SMILES
- CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)OS(=O)(=O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC
Names & Synonyms
- sulfatide
- Sulfatides
- 3'-Sulfogalactosylceramide
- Sulfoglycosphingolipids
- Tetracosanoyl-sulfatide
- tetracosanoyl sulfatide
- Sulfatoglycosphingolipids
- 151122-71-3
- 3' Sulfogalactosylceramide
- RefChem:1090666
- Epitope ID:139424
- 3'-Sulfo-galactosylceramide
- AC1O52SD
- CHEBI:60361
- DTXSID901110847
- orb1692146
- SCHEMBL25433418
- C48H93NO11S
- 1,3-Dimethyl-4-ethylcarbostyril
- DTXCID501542464
- AKOS040756332
- CID6451121
- CID:6451121
- 3-O-Sulfogalactosylceramide (d18:1/24:0)
- PD077234
- (3'-sulfo)Galbeta-Cer(d18:1/24:0)
- SID:123071348
- HY-145535
- CS-0375793
- 1-(3-O-sulfo-beta-D-galactosyl)-N-tetracosanoylsphingosine
- C24 3'-sulfo Galactosylceramide (d18:1/24:0)
- D013433
- Q27127214
- [(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)octadec-4-enoxy]oxan-4-yl] hydrogen sulfate
- Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-
- 1-(3-O-sulfo-|A-D-galactosyl)-N-tetracosanoylsphingosine
- -3,5-dihydroxy-2- -6-[ -3-hydroxy-2- octadec-4-enoxy]-4-sulfooxy-oxane
- -3,5-dihydroxy-2-6-[-3-hydroxy-2- octadec-4-enoxy]-4-sulfooxy-oxane
- [(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)octadec-4-enoxy]tetrahydropyran-4-yl] hydrogen sulfate
- 3688-74-2
- Tetracosanamide, N-((1S,2R,3E)-2-hydroxy-1-(((3-O-sulfo-beta-D-galactopyranosyl)oxy)methyl)-3-heptadecenyl)-
- [ -3,5-dihydroxy-2- -6-[ -3-hydroxy-2- octadec-4-enoxy]oxan-4-yl]hydrogensulfate
- (15Z)-N-((1S,2R,3E)-2-HYDROXY-1-{[(3-O-SULFO-BETA-D-GALACTOPYRANOSYL)OXY]METHYL}HEPTADEC-3-ENYL)TETRACOS-15-ENAMIDE
- (2R,3R,4S,5S,6R)-3,5-Dihydroxy-2-(((2S,3R,E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl hydrogen sulfate
- [(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
- [(2R,3S,4S,5R,6R)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)octadec-4-enoxy]oxan-4-yl]hydrogen sulfate
- CIS
- N-((1S,2R,3E)-2-Hydroxy-1-(((3-O-sulfo-beta-D-galactopyranosyl)oxy)methyl)-3-heptadecen-1-yl)tetracosanamide
- N-[(1S,2R,3E)-2-Hydroxy-1-[[(3-O-sulfo-I(2)-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]tetracosanamide
- N-{(2S,3R,4E)-3-hydroxy-1-[(3-O-sulfo-beta-D-galactopyranosyl)oxy]octadec-4-en-2-yl}tetracosanamide
- N/A
- Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-b-D-galactopyranosyl)oxy]methyl]-3-heptadecenyl]-